CymaBay Therapeutics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (28)

Latest Posts

About This Stock More About This Stock
Why Are Top Analysts Obsessed With These 3 Disruptive Stocks?
Article By: TipRanks
Sunday, December 3, 2017 12:53 PM EDT
Here we focus in on three stocks that have the power to disrupt- and have significant backing from the Street. All these stocks have a ‘Strong Buy’ rating from the best-performing analysts- and big upside potential from the current share price.
In this article: AMZN, CBAY, SEDG
Read
CymaBay Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, July 19, 2017 1:19 PM EDT
CymaBay Therapeutics, Inc., today announced the pricing of its previously announced underwritten public offering of 13,000,000 shares of its common stock at a public offering price of $6.50 per share.
In this article: CBAY
Read
5 Breakout Stocks For Superior Returns
Article By: Swarup Gupta
Friday, February 10, 2017 10:50 AM EDT
Utilizing a breakout investment strategy is a favored choice of active investors who are content only with returns superior to most other investments.
In this article: GNK, CBAY, CMRX, SMMT, MODN
Read
2 Biotech Lottery Tickets For Under $5
Article By: Bret Jensen
Tuesday, September 15, 2015 9:49 PM EDT
The high beta biotech sector has started to recover in recent weeks after almost dropping 20% from previous highs and thus avoiding an official “bear” market.
In this article: THLD, CBAY Also: AMGN, GILD
Read
Healthcare Review: CLVS, CBAY, PVCT, TNXP, SGEN
Article By: BioMedReports
Monday, September 29, 2014 5:50 PM EDT
Global equity markets fell on Monday as civil unrest in Hong Kong weighed on investor sentiment, while U.S. Treasury debt prices rose over uncertainty sparked by the protests.
In this article: PVCT, TNXP, SGEN, CLVS, CBAY
Read

PARTNER HEADLINES

Latest Tweets for $CBAY

No tweets yet!